Inventor
ALTHAUS HARALD
DE19 patents
⚠️ This page may combine multiple inventors who share the name “ALTHAUS HARALD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DADE BEHRING MARBURG GMBH
6 patentsUS7338770B2Mar 4, 2008
Human procalcitonin and the preparation and use thereof
DADE BEHRING MARBURG GMBH5 citations73
US6905687B2Jun 14, 2005
Human procalcitonin and the preparation and use thereof
DADE BEHRING MARBURG GMBH9 citations73
US6562946B2May 13, 2003
Human procalcitonin and the preparation and use thereof
DADE BEHRING MARBURG GMBH9 citations73
US6451311B2Sep 17, 2002
Anti-procalcitonin antibodies and the preparation and use thereof
DADE BEHRING MARBURG GMBH13 citations69
US6440747B2Aug 27, 2002
Stabilization of biological fluids by addition of sterol esters
DADE BEHRING MARBURG GMBH4 citations62
US7258989B2Aug 21, 2007
Carbohydrate deficient transferrin (CDT) -specific antibodies, their preparation and use
DADE BEHRING MARBURG GMBH1 citations51
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
6 patentsUS9869683B2Jan 16, 2018
Methods and kits for determining von Willebrand factor activity in the absence of ristocetin
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH2 citations70
US11262357B2Mar 1, 2022
Activation assay for the diagnosis of a heparin-induced thrombocytopenia
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH0 citations57
US11320439B2May 3, 2022
Binding assay for the diagnosis of a heparin-induced thrombocytopenia
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH0 citations51
US11953503B2Apr 9, 2024
Method for quantitatively determining a therapeutic TNF-alpha inhibitor
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH0 citations49
US10591490B2Mar 17, 2020
Methods and kits for determining von willebrand factor activity in the absence of ristocetin
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH0 citations49
US9469687B2Oct 18, 2016
Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereof
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH0 citations49
SIEMENS HEALTHCARE DIAGNOSTICS
2 patentsUS7951910B2May 31, 2011
Peptides with the marburg I polymorphism of factor VII-activating protease (FSAP) and their preparation and uses
SIEMENS HEALTHCARE DIAGNOSTICS11 citations82
US7622558B2Nov 24, 2009
Antibodies which are directed against the Marburg I polymorphism of factor VII-activating protease (FSAP), and their preparation and use
SIEMENS HEALTHCARE DIAGNOSTICS3 citations60
ALTHAUS HARALD
2 patentsUS9222942B2Dec 29, 2015
Methods and kits for determining von willebrand factor activity in the absence of ristocetin
ALTHAUS HARALD5 citations79
US8932820B2Jan 13, 2015
Methods and kits for determining von Willebrand factor activity in the absence of ristocetin and for determining the activity of ADAMTS-13 protease
ALTHAUS HARALD8 citations79